耳的外聚糖通过德-1-介导免疫调节和微生物群重塑减轻DSS诱导的大肠炎
Luísa Coutinho Coelho1, Luísa Dan Favilla1, Thais Bergmann de Castro1
1Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasilia, Federal District, Brasilia 70910-000, Brazil.
Pharmaceuticals (Basel, Switzerland)
|August 28, 2025
概括
通过改善肠道炎症和微生物群,Auricularia auricula多糖具有治疗性潜力. 这种效应通过Dectin-1受体进行介导,突出了炎症性肠病的新治疗策略.
科学领域:
- 免疫学
- 微生物学
- 药理学
背景情况:
- 性结肠炎 (UC) 涉及免疫失调和肠道失调.
- 研究用于治疗UC的天然化合物至关重要.
研究的目的:
- 探讨DSS诱导的大肠炎中的Auricularia auricula多糖的治疗潜力.
- 阐明Dectin-1受体在调解这些多糖的作用中的作用.
主要方法:
- 使用NMR进行 Auricularia auricula exopolysaccharide (EPS) 的表征
- 在DSS诱导的大肠炎的小鼠模型中对EPS治疗的评估 (野生型和Dectin-1淘汰小鼠).
- 分析便微生物组的变化和结肠炎症标志物.
主要成果:
- 通过调节IL-10和TNF-α等细胞因子,EPS治疗改善了野生型小鼠的炎症反应.
- 德克丁-1 绝杀小鼠没有表现出相同的治疗增强,表明受体依赖.
- 在WT和Dectin-1 KO小鼠中,EPS治疗改变了肠道微生物组合.
结论:
- 在炎症性肠道疾病中,EPS具有治疗潜力.
- 治疗效果与细胞因子调节和微生物群转移有关.
- 对于EPS所观察到的治疗效益来说,Dectin-1受体的识别是必不可少的.
相关概念视频
01:17Drugs for Treatment of Diarrhea-Predominant IBS
292
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.2K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K